Ignite Creation Date:
2025-12-25 @ 3:15 AM
Ignite Modification Date:
2025-12-26 @ 1:54 AM
Study NCT ID:
NCT05335005
Status:
COMPLETED
Last Update Posted:
2024-10-17
First Post:
2022-04-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-14
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-12
First Submit QC Date:
None
Study First Post Date:
2022-04-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-01-26
Results First Submit QC Date:
None
Results First Post Date:
2024-10-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-30
Last Update Post Date:
2024-10-17
Last Update Post Date Type:
ACTUAL